These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16270653)

  • 21. Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal.
    Elalamy I; Tribout B
    J Thromb Haemost; 2008 Jul; 6(7):1242-3; author reply 1243-6. PubMed ID: 19330935
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypersensitivity reactions to heparins.
    Gonzalez-Delgado P; Fernandez J
    Curr Opin Allergy Clin Immunol; 2016 Aug; 16(4):315-22. PubMed ID: 27285488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
    Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
    Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 25. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
    Papadopoulos S; Flynn JD; Lewis DA
    Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of cutaneous type IV hypersensitivity reactions induced by heparin.
    Ludwig RJ; Schindewolf M; Utikal J; Lindhoff-Last E; Boehncke WH
    Thromb Haemost; 2006 Nov; 96(5):611-7. PubMed ID: 17080218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux.
    Harr T; Scherer K; Tsakiris DA; Bircher AJ
    Allergy; 2006 Jun; 61(6):787-8. PubMed ID: 16677252
    [No Abstract]   [Full Text] [Related]  

  • 28. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
    Trautmann A; Seitz CS
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
    Davidson BL; Büller HR; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob GE; Segers AE; Lensing AW;
    J Thromb Haemost; 2007 Jun; 5(6):1191-4. PubMed ID: 17403087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An approach to heparin and lidocaine hypersensitivity for the interventional nephrologist.
    Sequeira A
    Semin Dial; 2014; 27(5):512-7. PubMed ID: 24397566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Delayed-type allergy for heparin and fractions of low-molecular-weight heparin].
    de Kort WJ; van der Meer YG; de Groot AC
    Ned Tijdschr Geneeskd; 1992 Nov; 136(48):2379-80. PubMed ID: 1334235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful heparin desensitization: a case report and review of the literature.
    Dave S; Park MA
    J Card Surg; 2008; 23(4):394-7. PubMed ID: 18598335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin allergy: successful desensitization for cardiopulmonary bypass.
    Parekh K; Burkhart HM; Hatab A; Ross A; Muller BA
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1455-6. PubMed ID: 16256803
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug allergy syndromes in adults, what is the right time to test for hypersensitivity?].
    Nieminen E; Hyry H; Lauerma A; Granlund H; Haahtela T
    Duodecim; 2004; 120(15):1885-90. PubMed ID: 15508762
    [No Abstract]   [Full Text] [Related]  

  • 37. Eosinophilic panniculitis and hypereosinophilia caused by hypersensitivity to calcium heparin.
    Yasuda M; Abe M; Yamanaka M; Amano H; Tamura A; Ishikawa O
    Eur J Dermatol; 2010; 20(3):401-2. PubMed ID: 20400387
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of electrophoresis for detecting increased sensitivity to drugs in drug allergy patients with a skin lesion].
    Dokhnenko AM
    Vestn Dermatol Venerol; 1977 Feb; (2):74-7. PubMed ID: 855440
    [No Abstract]   [Full Text] [Related]  

  • 40. Fondaparinux as anticoagulant in a pregnant woman with heparin allergy.
    Wijesiriwardana A; Lees DA; Lush C
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):147-9. PubMed ID: 16479197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.